Get the latest news in perioperative business operations and management before the OR Business Management Conference from OR Manager.

Want this news sent directly to you each month?
Subscribe to our OR Business eLetter for free!


NPDB launches hospital attestation initiative

Editor’s Note The Joint Commission on February 14 announced that the National Practitioner Data Bank (NPDB) has launched a new initiative for US hospitals to complete their attestation when renewing their NPDB registrations. The NPDB is a repository of reports on medical malpractice payments and adverse actions related to healthcare practitioners, providers, and suppliers. An […]

READ MORE

CMS grants exceptions to ASCs in areas affected by natural disasters

Editor’s Note Because of the impact of several recent natural disasters, the Centers for Medicare & Medicaid Services (CMS) is granting exceptions for Medicare quality reporting requirements to ASCs in affected areas, the February 12 ASCA News reports. Exceptions include: ASCs in two California counties affected by wildfires ASCs located in Mississippi counties affected by […]

READ MORE

Study: OR skullcaps not linked to SSIs

Editor’s Note Strictly enforcing a ban on skullcaps in the OR had no impact on surgical site infection (SSI) rates in this study, presented at the annual Academic Surgical Congress in Jacksonville, Florida. The analysis included American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) data on 1,901 patients who had clean or […]

READ MORE

Joint Commission seeking eCQM success stories

Editor’s Note The Joint Commission on February 14 announced that accredited hospitals should start thinking about electronic clinical quality measure (eCQM) success stories to share in the 2018 Pioneers in Quality Proven Practices Collection. Proven Practices was launched last year and is a peer-to-peer sharing of specific practices that an organization does exceptionally well. If […]

READ MORE

FDA permits marketing of new blood test for concussions

Editor’s Note The Food & Drug Administration (FDA) on February 14 authorized marketing of the first blood test to help evaluate concussions in adults and reduce the need for CT scans. The Banyan Brain Trauma Indicator works by measuring levels of proteins (ie, UCH-L1 and GFAP) that are released from the brain into the patient’s […]

READ MORE

Neurosurgical products market poised for growth

Editor’s Note Wise Guy Reports predicts the global market for neurosurgical products will see a 10.5% compound annual growth rate through 2023 because of the growing availability of neurosurgical devices and increasing popularity of minimally invasive surgeries, the February 9 Becker’s Spine Review reports. Key players in the market, which is led by the neurostimulation […]

READ MORE

FDA permits marketing of software to alert providers of potential strokes in patients

Editor’s Note The Food & Drug Administration (FDA) on February 13 announced that it is permitting the marketing of clinical decision support software that alerts providers to potential strokes in their patients. The Viz.AI Contact application is designed to analyze computed tomography images of the brain and send a text notification to a neurovascular specialist […]

READ MORE

FDA: Class I recall of HeartStart MRx Defibrillator

Editor’s Note The Food & Drug Administration (FDA) on February 9 classified the recall by Philips Electronics (Andover, Massachusetts) of its HeartStart MRx Defibrillator as Class I, the most serious. The recall was initiated because of micro cracks in the gas discharge tube that allow internal gasses to escape and can cause the tube to […]

READ MORE

Budget deal includes big changes for healthcare

Editor’s Note The US Congress on February 9 passed a budget deal that will have a significant impact across nearly every sector of the healthcare industry, the March 9 Business Insider reports. Among the initiatives are: $2 billion for the National Institutes of Health $6 billion to combat the opioid crisis $4 billion for VA […]

READ MORE

FDA: New imaging technology promises stable supply of imaging isotope

Editor’s Note The Food & Drug Administration (FDA) Commissioner, Scott Gottlieb, MD, on February 8 announced the role the FDA played in the groundbreaking effort to develop a new imaging technology−the RadioGenix System. The technology, which resulted from a collaboration across the federal government and industry, has the potential to benefit many patients and restore […]

READ MORE